Sat, Jul 12, 2014, 3:54 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • eyesandears51 eyesandears51 Apr 15, 2013 9:00 PM Flag

    SRPT....Great Company.....Stock May Be Ahead of it's Ski's

    Good summary of SRPT stock's near term risk/rewards from a brokerage MB.
    "I suggest caution. Option open put interest is highest @ $ 26 and $ 30 for April 20, $ 17.50 and $ 25 for May. The market was expecting a positive indication from the FDA this month for expedited review. The FDA requested additional information with the determination moved out at least one quarter. Many have conjectured that a negative response would have resulted in a retrenchment to the low to mid $20's; a corresponding favorable indication of expedited approval was expected to propel the stock to the low $ 50's. After hours ranged from $ 33.92- $ 38, closing @ $ 36.68. The delay and request for more documentation increases the risk threshold and is therefore moderately negative, hence the pullback. A combination of less than positive news from the FDA, and a choppy market suggest a price in the mid $ 30's may be problematic. Please also consider that short % of Float (as of Mar 28, 2013) is very high at 34%. IMO adding to a position in the high $ 20's to low $ 30's offers a better risk adjusted return."

    Full disclosure.I have significant holding in the stock @ $ 23.65, and $ 33.31 respectively, but sold half my position last week @ $ 42.05"

21.98-0.56(-2.48%)Jul 11 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.